Acute Investment Advisory’s Xtrackers USD High Yield Corporate Bond ETF HYLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,253
Closed -$649K 29
2022
Q2
$649K Sell
19,253
-16,874
-47% -$601K 0.5% 25
2022
Q1
$1.36M Sell
36,127
-270,813
-88% -$10.4M 1.02% 24
2021
Q4
$12.2M Buy
+306,940
New +$12.2M 8.93% 2

Other funds holding HYLB

Acute Investment Advisory's HYLB Position: Q3 2022 in Review

Acute Investment Advisory sold out of Xtrackers USD High Yield Corporate Bond ETF (HYLB) in Q3 2022, closing a stake of 19,253 shares — an estimated $649K sold.

Acute Investment Advisory first reported a position in HYLB in Q4 2021 and held it in 3 quarters. The position peaked at $12.2M in Q4 2021. 206 funds tracked by Wall St. Rank hold HYLB as of Q3 2022.

  • Acute Investment Advisory reported no remaining Xtrackers USD High Yield Corporate Bond ETF position as of Q3 2022 after selling out during the quarter.
  • Acute Investment Advisory sold 19,253 Xtrackers USD High Yield Corporate Bond ETF shares in Q3 2022, an estimated $649K.
  • Acute Investment Advisory first reported a position in Xtrackers USD High Yield Corporate Bond ETF in Q4 2021 and held it in 3 quarters.
  • Acute Investment Advisory's Xtrackers USD High Yield Corporate Bond ETF position peaked at $12.2M in Q4 2021.
  • 206 funds tracked by Wall St. Rank held Xtrackers USD High Yield Corporate Bond ETF as of Q3 2022.

Based on Acute Investment Advisory's 13F filing for Q3 2022, filed 20 Oct 2022.